Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$47.15 +0.18 (+0.38%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Cash & Equivalents (2010 - 2026)

Updated

Rigel Pharmaceuticals' Cash & Equivalents came in at $60.82 million for Q2 2026, up 13.9% from $53.41 million a year earlier and up 149.1% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Cash & Equivalents (2010 - 2026) Analysis & Trends

At the end of FY2025, Rigel Pharmaceuticals' Cash & Equivalents was $40.58 million, down 28.5% from FY2024.

  • Cash & Equivalents carries a five-year compound annual growth rate of 6.0% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $56.75 million in FY2024 (+73.1%), $32.79 million in FY2023 (+34.0%), $24.46 million in FY2022 (+29.5%) and $18.89 million in FY2021 (-37.8%).
  • The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q2 2021.
  • Year-over-year, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 18.3%.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2023 (growth of 79.4%), and the weakest in Q2 2022 (a decline of 67.9%).
  • Business Quant data shows RIGL's Cash & Equivalents at $24.41 million (Q1 2026), $40.58 million (Q4 2025) and $48.53 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 20.42 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.57 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 7.62 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.18 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 976.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 6.14 Bn
10 Rigel Pharmaceuticals 899.44 Mn 365.32 Mn 70.18 Mn 60.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.82 Mn
Mar 31, 2026 24.41 Mn
Dec 31, 2025 40.58 Mn
Sep 30, 2025 48.53 Mn
Jun 30, 2025 53.41 Mn
Mar 31, 2025 45.73 Mn
Dec 31, 2024 56.75 Mn
Sep 30, 2024 51.69 Mn
Jun 30, 2024 36.05 Mn
Mar 31, 2024 25.57 Mn
Dec 31, 2023 32.79 Mn
Sep 30, 2023 45.41 Mn
Jun 30, 2023 48.81 Mn
Mar 31, 2023 40.29 Mn
Dec 31, 2022 24.46 Mn
Sep 30, 2022 29.87 Mn
Jun 30, 2022 27.20 Mn
Mar 31, 2022 24.68 Mn
Dec 31, 2021 18.89 Mn
Sep 30, 2021 30.40 Mn
API Access

Rigel Pharmaceuticals Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RIGL&period=max&api_key=YOUR_API_KEY